Array BioPharma (ARRY) Tops Q3 EPS by 1c; Receives $80 Million Funding Commitment
Tweet Send to a Friend
Array BioPharma Inc. (Nasdaq: ARRY) reports a Q3 loss of $0.51, 1 cent better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
